194 related articles for article (PubMed ID: 26324128)
1. Nuclear Export as a Novel Therapeutic Target: The CRM1 Connection.
Lu C; Figueroa JA; Liu Z; Konala V; Aulakh A; Verma R; Cobos E; Chiriva-Internati M; Gao W
Curr Cancer Drug Targets; 2015; 15(7):575-92. PubMed ID: 26324128
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of CRM1-dependent nuclear export sensitizes malignant cells to cytotoxic and targeted agents.
Turner JG; Dawson J; Cubitt CL; Baz R; Sullivan DM
Semin Cancer Biol; 2014 Aug; 27():62-73. PubMed ID: 24631834
[TBL] [Abstract][Full Text] [Related]
3. Targeting the nuclear transport machinery by rational drug design.
Mao L; Yang Y
Curr Pharm Des; 2013; 19(12):2318-25. PubMed ID: 23082981
[TBL] [Abstract][Full Text] [Related]
4. Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) protein.
Ishizawa J; Kojima K; Hail N; Tabe Y; Andreeff M
Pharmacol Ther; 2015 Sep; 153():25-35. PubMed ID: 26048327
[TBL] [Abstract][Full Text] [Related]
5. Ratjadone and leptomycin B block CRM1-dependent nuclear export by identical mechanisms.
Meissner T; Krause E; Vinkemeier U
FEBS Lett; 2004 Oct; 576(1-2):27-30. PubMed ID: 15474004
[TBL] [Abstract][Full Text] [Related]
6. CRM1-dependent, but not ARE-mediated, nuclear export of IFN-alpha1 mRNA.
Kimura T; Hashimoto I; Nagase T; Fujisawa J
J Cell Sci; 2004 May; 117(Pt 11):2259-70. PubMed ID: 15126627
[TBL] [Abstract][Full Text] [Related]
7. Novel reversible selective inhibitor of nuclear export shows that CRM1 is a target in colorectal cancer cells.
Niu M; Chong Y; Han Y; Liu X
Cancer Biol Ther; 2015; 16(7):1110-8. PubMed ID: 25996664
[TBL] [Abstract][Full Text] [Related]
8. Leptomycin B alters the subcellular distribution of CRM1 (Exportin 1).
Rahmani K; Dean DA
Biochem Biophys Res Commun; 2017 Jun; 488(2):253-258. PubMed ID: 28412356
[TBL] [Abstract][Full Text] [Related]
9. Importins and exportins as therapeutic targets in cancer.
Mahipal A; Malafa M
Pharmacol Ther; 2016 Aug; 164():135-43. PubMed ID: 27113410
[TBL] [Abstract][Full Text] [Related]
10. CRM1 is a direct cellular target of the natural anti-cancer agent plumbagin.
Liu X; Niu M; Xu X; Cai W; Zeng L; Zhou X; Yu R; Xu K
J Pharmacol Sci; 2014; 124(4):486-93. PubMed ID: 24739265
[TBL] [Abstract][Full Text] [Related]
11. XPO1-dependent nuclear export as a target for cancer therapy.
Azizian NG; Li Y
J Hematol Oncol; 2020 Jun; 13(1):61. PubMed ID: 32487143
[TBL] [Abstract][Full Text] [Related]
12. Type 1 parathyroid hormone receptor (PTH1R) nuclear trafficking: regulation of PTH1R nuclear-cytoplasmic shuttling by importin-alpha/beta and chromosomal region maintenance 1/exportin 1.
Pickard BW; Hodsman AB; Fraher LJ; Watson PH
Endocrinology; 2007 May; 148(5):2282-9. PubMed ID: 17317770
[TBL] [Abstract][Full Text] [Related]
13. Nuclear export of proteins and drug resistance in cancer.
Turner JG; Dawson J; Sullivan DM
Biochem Pharmacol; 2012 Apr; 83(8):1021-32. PubMed ID: 22209898
[TBL] [Abstract][Full Text] [Related]
14. Chromosome Region Maintenance 1 (XPO1/CRM1) as an Anticancer Target and Discovery of Its Inhibitor.
Liu S; Qiao W; Sun Q; Luo Y
J Med Chem; 2021 Nov; 64(21):15534-15548. PubMed ID: 34669417
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of CRM1-mediated nuclear export of influenza A nucleoprotein and nuclear export protein as a novel target for antiviral drug development.
Chutiwitoonchai N; Mano T; Kakisaka M; Sato H; Kondoh Y; Osada H; Kotani O; Yokoyama M; Sato H; Aida Y
Virology; 2017 Jul; 507():32-39. PubMed ID: 28399435
[TBL] [Abstract][Full Text] [Related]
16. Atomic basis of CRM1-cargo recognition, release and inhibition.
Fung HY; Chook YM
Semin Cancer Biol; 2014 Aug; 27():52-61. PubMed ID: 24631835
[TBL] [Abstract][Full Text] [Related]
17. CRM1-dependent transport supports cytoplasmic accumulation of adenoviral early transcripts.
Schmid M; Gonzalez RA; Dobner T
J Virol; 2012 Feb; 86(4):2282-92. PubMed ID: 22171254
[TBL] [Abstract][Full Text] [Related]
18. CRM1-mediated nuclear export of proteins and drug resistance in cancer.
Turner JG; Sullivan DM
Curr Med Chem; 2008; 15(26):2648-55. PubMed ID: 18991627
[TBL] [Abstract][Full Text] [Related]
19. Nucleo-cytoplasmic transport as a therapeutic target of cancer.
Gravina GL; Senapedis W; McCauley D; Baloglu E; Shacham S; Festuccia C
J Hematol Oncol; 2014 Dec; 7():85. PubMed ID: 25476752
[TBL] [Abstract][Full Text] [Related]
20. Nuclear targeting of adenovirus type 2 requires CRM1-mediated nuclear export.
Strunze S; Trotman LC; Boucke K; Greber UF
Mol Biol Cell; 2005 Jun; 16(6):2999-3009. PubMed ID: 15814838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]